| Trial ID: | L3877 |
| Source ID: | NCT03226210
|
| Associated Drug: |
Aspart Insulin Or Lipro Insulin
|
| Title: |
Comparison of Efficacy and Safety of Prandilin and NovoRapid in Newly Diagnosed Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: aspart insulin or lipro insulin
|
| Outcome Measures: |
Primary: The primary endpoint was the between-group difference of MAGE, the 24-h mean amplitude of glycemic excursions (MAGE), 14 days |
|
| Sponsor/Collaborators: |
Sponsor: Nanjing First Hospital, Nanjing Medical University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
110
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2015-02-01
|
| Completion Date: |
2016-07-01
|
| Results First Posted: |
|
| Last Update Posted: |
2017-07-21
|
| Locations: |
Nanjing First Hostital, Nanjing, Jiangsu, 210000, China
|
| URL: |
https://clinicaltrials.gov/show/NCT03226210
|
